Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minn; Division of Cardiology, Department of Internal Medicine, Soonchunhyang University Hospital, Seoul, South Korea.
Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minn.
J Allergy Clin Immunol Pract. 2016 Sep-Oct;4(5):917-23. doi: 10.1016/j.jaip.2016.02.018. Epub 2016 May 4.
The role of asthma status and characteristics of asthma in the risk of myocardial infarction (MI) are poorly understood.
We determined whether asthma and its characteristics are associated with risk of MI.
The study was designed as a population-based retrospective case-control study, which included all eligible incident MI cases between November 1, 2002, and May 31, 2006, and their matched controls. Asthma was ascertained using predetermined criteria. Active (current) asthma was defined as the occurrence of asthma-related episodes (asthma symptoms, use of asthma medications, unscheduled medical or emergency department visit, or hospitalization for asthma) within 1 year before MI index date.
There were 543 eligible incident MI cases during the study period. Of the 543 MI cases, 81 (15%) had a history of asthma before index date of MI, whereas 52 of 543 controls (10%) had such a history (adjusted odds ratio [OR]: 1.68; 95% CI: 1.06-2.66) adjusting for risk factors for MI and comorbid conditions (excluding chronic obstructive lung disease). Although inactive asthma did not increase the risk of MI, individuals with active asthma had a higher odds of MI, compared with those without asthma (adjusted OR: 3.18; 95% CI: 1.57-6.44) without controlling for chronic obstructive pulmonary disease (COPD). After adjusting for COPD, although asthma overall was no longer statistically significant (adjusted OR: 1.34, 95% CI: 0.84-2.15), active asthma still was associated (adjusted OR: 2.33, 95% CI: 1.12-4.82).
Active asthma is an unrecognized risk factor for MI. Further studies are needed to assess the role of asthma control and medications in the risk of MI.
哮喘状况和哮喘特征在心肌梗死(MI)风险中的作用尚未得到充分认识。
我们旨在确定哮喘及其特征是否与 MI 风险相关。
该研究设计为基于人群的回顾性病例对照研究,包括 2002 年 11 月 1 日至 2006 年 5 月 31 日期间所有符合条件的新发 MI 病例及其匹配对照。哮喘通过预定标准确定。活动性(当前)哮喘定义为在 MI 指数日期前 1 年内发生哮喘相关发作(哮喘症状、使用哮喘药物、非计划的医疗或急诊就诊或因哮喘住院)。
在研究期间,有 543 例符合条件的新发 MI 病例。在 543 例 MI 病例中,有 81 例(15%)在 MI 指数日期之前有哮喘史,而 52 例(10%)对照有哮喘史(调整后的优势比 [OR]:1.68;95%CI:1.06-2.66),调整了 MI 和合并症(不包括慢性阻塞性肺疾病)的危险因素。虽然非活动性哮喘不会增加 MI 的风险,但与无哮喘者相比,患有活动性哮喘的个体发生 MI 的可能性更高(调整后的 OR:3.18;95%CI:1.57-6.44),且不控制慢性阻塞性肺疾病(COPD)。调整 COPD 后,尽管哮喘整体上不再具有统计学意义(调整后的 OR:1.34,95%CI:0.84-2.15),但仍与活动性哮喘相关(调整后的 OR:2.33,95%CI:1.12-4.82)。
活动性哮喘是 MI 的一个未被认识的危险因素。需要进一步研究来评估哮喘控制和药物在 MI 风险中的作用。